Evidence map›Paper›PMID 42571105›Full record

ArticleDermatology research and practice2026

Effect of Transcutol P on Percutaneous Absorption of Gel Containing Pure Synthetic Caffeine or Plant-Extracted Natural Caffeine.

Nastaran Seyyed Abbasi, Fatemeh Soltanmohammadi, Mohammad Charkhpour, Javad Shokri

Abstract read
In one paragraph

Article in Dermatology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nastaran Seyyed AbbasiStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran, tbzmed.ac.ir.ORCID https://orcid.org/0009-0000-4726-4968
Fatemeh SoltanmohammadiStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran, tbzmed.ac.ir.ORCID https://orcid.org/0009-0006-9719-4842
Mohammad CharkhpourDepartment of Pharmacology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran, tbzmed.ac.ir.ORCID https://orcid.org/0000-0003-1097-1559
Javad ShokriDepartment of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran, tbzmed.ac.ir.ORCID https://orcid.org/0000-0002-3525-0566

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Caffeine, a safe methylxanthine, has been widely used for the treatment of skin diseases such as cellulite, hair loss, aging, and psoriasis. However, its skin penetration is low. Transcutol is a biocompatible, nonvolatile permeation enhancer which solubilize large number of drugs and does not change the integrity of the skin structure. Materials and methods: In this study, the skin permeability of synthetic and natural caffeine gels was compared by ex vivo experiments. Furthermore, Transcutol P was used as a permeation enhancer, and its impact on skin permeation enhancement was determined. Results: The skin penetration of caffeine from the formulation containing coffee extract, a type of natural caffeine, is higher than that of the formulation containing pure synthetic caffeine. This effect is likely due to the presence of coffee, which can act as a skin permeation enhancer. Additionally, the use of Transcutol P in a formulation containing coffee extract at a concentration of 2.5% caused the highest amount of flux. Therefore, the formulation of gel containing natural caffeine along with 2.5% Transcutol is optimal and can be used for further studies. Conclusion: It can be concluded that the addition of 2.5% Transcutol P in the formulation containing coffee extract resulted in the highest skin permeation.

Indexed as

caffeinecelluliteskinskin permeabilityTranscutol

Identifiers

PMID42571105
PMCPMC13451620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.